Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph-BLineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 Trial

BLOOD(2023)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要